Endometrial ablation is process that facilitates the destruction of endometrium or thin layer of the uterine wall, in context to treat abnormal heavy uterine bleeding if not controlled with any means of medication. Endometrial ablation is not recommended in women with disorders of endometrium, endometrial hyperplasia, cancer of uterus, recent pregnancy and certain infections of uterus, as per the American College of Obstetrics and Gynecology (ACOG). Depending on technique and type of patient under treatment, different endometrial ablation methods are present which includes such as Radiofrequency, heated fluid, heated balloon, electrosurgery, freezing, microwave ablation techniques.
According to the Centers for Disease Control and Prevention (CDC), 10 million American women are affected with heavy bleeding (menorrhagia) each year. The likely cause of abnormal bleeding includes hormonal imbalance disturbance in post menopause, fibroids or polyps in uterus, birth control pills, endometrium cancer and use of intrauterine device (IUD).
Endometrial ablation are generally done through either resectoscopic ablation or non-resectoscopic ablation techniques. Resectoscopic ablation is minimal invasive technique to treat ablation by using hysteroscope to visually guide the process. Conversely non-resectoscopic ablation is performed with device inserted in uterine cavity and destroy uterine lining uniformly. Both the techniques are efficient in providing the relief to patient and reduction of menstrual bleeding. Due to the fact that, non-resectoscopic methods requires less specialized training, shorter operative time and they can be performed in outpatient setting, it is a widely preferred ablation technique over resectoscopic ablation.
With the growing prevalence of gynecology disorders such as ovarian cysts, Polycystic Ovarian Syndrome (PCOS), acne, genital tract infections, Pelvic inflammatory disease (PID), endometriosis, abnormal endometrium bleeding, global adoption of endometrial ablation devices would increase dramatically leading to the growth of endometrial ablation market in near future.
Endometrial ablation market taxonomy:
By Device Type:
By Ablation methods:
By End User:
Recent advancements in endometrial ablation market
Hologic Inc., in February 2017, launched NovaSure ADVANCED, the FDA approved, revised version of NovaSure in endometrial ablation system, for the treatment of abnormal uterine bleeding. NovaSure Advanced offers the 6mm slimmer diameter which facilitates patient comfort and providing 13% more working length than the previous device. Additionally this new device is equipped with a corn shaped cervical seal which creates increased sealing surface within cervical canal, providing more working length.
Key players operating in endometrial ablation market are RF Medical, Erbe Inc. MedGyn Inc., Ri.Mos.Inc. Biosense Webster Inc., Hansen Medical Inc. Biotronik, Smith & Nephew plc, Arthrex, Wallach.
Asia Pacific is highly growing endometrial ablation market offers lucrative growth in near future
In terms of Geography, the global endometrial ablation market is classified into North America, Europe and Asia pacific regions. Endometrial ablation market is dominated by North America, due to their easy accessibility to recently introduced advanced ablation technology, ease of use, less treatment time and outpatient facility. Followed with Asia pacific regions anticipated the future opportunities in near future due to growing numbers in gynecological disorders in the regions and rising awareness leads to drive endometrial ablation market.